News

Company News

Industry News

Professor Fang Zhaohui and his entourage visited Huibang Biology for a visit and exchange

Professor Fang Zhaohui and his entourage visited Huibang Biology for a visit and exchange

On the afternoon of March 9, 2021, Professor Fang Zhaohui, a famous doctor from Jianghuai, director of Anhui Institute of Diabetes Prevention and Treatment of Traditional Chinese Medicine, and doctoral supervisor of Anhui University of Traditional Chinese Medicine, visited our company for visits, guidance and exchanges.

10

2021-03

Goddess' Day丨Huibang is beautiful because of you

Goddess' Day丨Huibang is beautiful because of you

In March of Yangchun, everything recovers, flowers bloom, and there is vitality everywhere. The spring of 2021 will come as promised on the east wind. In this March full of spring, full of poetry and vitality, we ushered in the 111th "March 8" International Women's Day!

08

2021-03

Huibang Biotech's

Huibang Biotech's "Planned Treatment for Premature Rupture of Membranes" was selected as one of the fifth batch of health and health appropriate technology promotion projects in the province

Recently, Huibang Biotech's "Planned Treatment for Premature Rupture of Membranes" was successfully selected into the fifth batch of health technology promotion projects in Anhui Province.

24

2021-02

To create an industrial chain, Huibang Biological will increase the research and development of IVD innovative products with its original ability, and continue to develop the raw material market

To create an industrial chain, Huibang Biological will increase the research and development of IVD innovative products with its original ability, and continue to develop the raw material market

Recently, Anhui Huibang Bioengineering Co., Ltd. (hereinafter referred to as "Huibang Bio") , an IVD manufacturer , announced the completion of the second strategic financing. This round of financing was jointly completed by Jiaxing Qihui and Saizhi Capital. The proceeds from the financing will be used to accelerate product development. Post-launch marketing.

28

2021-01

The journey is tens of thousands of miles, the wind is vigorous, and the heavy responsibility is imminent, and we will start again!

The journey is tens of thousands of miles, the wind is vigorous, and the heavy responsibility is imminent, and we will start again!

15

2021-01

In 2020, Hefei High-tech Zone's

In 2020, Hefei High-tech Zone's "Yangtze River Delta Regional Medical Device Registrant System" policy interpretation and theme seminar was successfully held

On the morning of August 1, the 2020 Hefei High-tech Zone "Yangtze River Delta Regional Medical Device Registrant System" Policy Interpretation and Theme Seminar hosted by the Management Committee of Hefei High-tech Zone, hosted by the High-tech Zone Investment Promotion Bureau and High-tech Company, was held in the High-tech Zone Held in the conference hall on the first floor of Building B of the Management Committee. Zhu Dehong, deputy director of the Medical Device Production Supervision Division of Anhui Provincial Food and Drug Administration, Xiang Min, member of the Working Committee and deputy director of the Management Committee of Hefei High-tech Zone, the person in charge of the Investment Promotion Bureau of the High-tech Zone, and the person in charge of Gaochuang shares attended the meeting. More than 60 corporate executives from the medical technology and medical device industries in the high-tech zone attended the meeting.

03

2020-08

Fighting the epidemic with me: Huibang Biology declares national key research and development projects

Fighting the epidemic with me: Huibang Biology declares national key research and development projects

Fighting the epidemic has me: Anhui Huibang Bioengineering Co., Ltd. applied for the national key research and development project, gave full play to its technical advantages, and immediately organized a team of experts to carry out the research and development of "New Coronavirus (2019-n COV) IgG/IgM Antibody Detection Kit", As a key guarantee enterprise for epidemic prevention and control in Anhui Province, it is duty-bound to solve problems for the people and the government!

18

2020-02

Huibang Biotechnology's

Huibang Biotechnology's "Abortion Prevention and Preterm Birth Detection Project" won the title of Lianzhong's 2019 Popular Star Product

Features and advantages: double quantitative, the first in China. Only one sampling is required. It can detect two indicators of IGFBP-1 and fFN at the same time; quantitative analysis can provide a more accurate assessment of amniotic fluid leakage and premature birth risk, and provide a more accurate reference for treatment plans. Anhui Huibang Bioengineering Co., Ltd.

21

2019-11

< 12345 >